Targeting cholesterol esterification sensitizes liver cancer to CD8+ T cell attack by impairing metabolic and redox resilience
Authors:
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- National Key Research and Development Program of China Stem Cell and Translational Research
This publication has 38 references indexed in Scilit:
- CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy responseCell, 2026
- Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunityCancer Cell, 2023
- CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4Cancer Cell, 2022
- The Importance of the Immunosuppressive Regime on Hepatocellular Carcinoma Recurrence After Liver TransplantationJournal of Gastrointestinal Cancer, 2021
- Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor ImmunityCell, 2020
- Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant CandidatesClinical Gastroenterology and Hepatology, 2019
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of diseaseHepatology, 2017
- Primary, Adaptive, and Acquired Resistance to Cancer ImmunotherapyCell, 2017
- Recurrence of Hepatocellular Carcinoma Following Liver TransplantationArchives of Surgery, 2008
- The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot studyHepatology, 1997